Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-4598
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients ; volume:20 ; number:1 ; day:29 ; month:4 ; year:2021 ; pages:1-6 ; date:12.2021
Molecular cancer ; 20, Heft 1 (29.4.2021), 1-6, 12.2021
- Urheber
-
Herrera, Mercedes
Berral-González, Alberto
López-Cade, Igor
Galindo-Pumariño, Cristina
Bueno-Fortes, Santiago
Martín-Merino, Manuel
Carrato, Alfredo
Ocaña, Alberto
De La Pinta, Carolina
López-Alfonso, Ana
Peña, Cristina
García-Barberán, Vanesa
De Las Rivas, Javier
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-021-01367-x
- URN
-
urn:nbn:de:101:1-2021061620524760028611
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.01.2025, 02:27 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Herrera, Mercedes
- Berral-González, Alberto
- López-Cade, Igor
- Galindo-Pumariño, Cristina
- Bueno-Fortes, Santiago
- Martín-Merino, Manuel
- Carrato, Alfredo
- Ocaña, Alberto
- De La Pinta, Carolina
- López-Alfonso, Ana
- Peña, Cristina
- García-Barberán, Vanesa
- De Las Rivas, Javier
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cancer-associated fibroblast-derived gene signatures predict radiotherapeutic survival in prostate cancer patients
Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression
What is new in cancer-associated fibroblast biomarkers?
Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer
Cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter
Cancer‐Associated Fibroblast‐Induced Remodeling of Tumor Microenvironment in Recurrent Bladder Cancer
Deciphering the temporal heterogeneity of cancer-associated fibroblast subpopulations in breast cancer
Cancer-associated fibroblast infiltration in gastric cancer: the discrepancy in subtypes pathways and immunosuppression
BRCA1 mutation promotes sprouting angiogenesis in inflammatory cancer-associated fibroblast of triple-negative breast cancer
Pancreatic cancer cell- and cancer-associated fibroblast-derived exosomes in disease progression, metastasis, and therapy
Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody
Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer‐Associated Fibroblast Activation
Cancer-associated fibroblast-derived gene signatures predict radiotherapeutic survival in prostate cancer patients
Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression
What is new in cancer-associated fibroblast biomarkers?
Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer
Cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter
Cancer‐Associated Fibroblast‐Induced Remodeling of Tumor Microenvironment in Recurrent Bladder Cancer
Deciphering the temporal heterogeneity of cancer-associated fibroblast subpopulations in breast cancer
Cancer-associated fibroblast infiltration in gastric cancer: the discrepancy in subtypes pathways and immunosuppression
BRCA1 mutation promotes sprouting angiogenesis in inflammatory cancer-associated fibroblast of triple-negative breast cancer
Pancreatic cancer cell- and cancer-associated fibroblast-derived exosomes in disease progression, metastasis, and therapy
Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody
Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer‐Associated Fibroblast Activation
Cancer-associated fibroblast-derived gene signatures predict radiotherapeutic survival in prostate cancer patients
Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression
What is new in cancer-associated fibroblast biomarkers?
Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer
Cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter
Cancer‐Associated Fibroblast‐Induced Remodeling of Tumor Microenvironment in Recurrent Bladder Cancer
Deciphering the temporal heterogeneity of cancer-associated fibroblast subpopulations in breast cancer
Cancer-associated fibroblast infiltration in gastric cancer: the discrepancy in subtypes pathways and immunosuppression
BRCA1 mutation promotes sprouting angiogenesis in inflammatory cancer-associated fibroblast of triple-negative breast cancer
Pancreatic cancer cell- and cancer-associated fibroblast-derived exosomes in disease progression, metastasis, and therapy
Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody